Bausch’s Papa Says ‘Transformation on Track’ as Debt Paydown Continues

The turnaround at Quebec-based Bausch Health Cos. appeared to take another step forward Tuesday, after the company reported positive organic growth for the third quarter, sending shares up more than five percent in Toronto, according to a Financial Post report.

Bausch, which changed its name from Valeant Pharmaceuticals in July, has been digging out from a pile of debt and legal issues ever since it was swept up in fraud allegations that sparked a spectacular share price collapse.

Read the full article.